House Ways and Means · Member dossier
Kevin Hern
Republican of Oklahoma's 1st District. In the House since 2018. Sits on the Health Subcommittee.
2026 election
Won another office
Hern won the U.S. Senate seat Markwayne Mullin vacated, defeating Democrat N'Kiyla Jasmine Thomas; the AP called it with Hern at 60 percent.
Source: KOKH FOX 25 Oklahoma City, Kevin Hern wins U.S. Senate seat vacated by Markwayne Mullin
Who funds the campaign
Healthcare PAC money, 2026 cycle.
Contributions from political action committees in healthcare to the Hern campaign committee. Individual donations are not counted.
By sector
- Pharmaceuticals$72,000
- Health Professionals$34,000
- Insurance$30,500
- Health Services/HMOs$16,000
- Hospitals & Nursing Homes$7,000
93 contributions. Sector labels are the Rojas Report's.
Largest healthcare PACs
- Health Care Service Corporation Employees' Political Action CommitteeInsurance$10,000
- The Cigna Group Employee Political Action CommitteeInsurance$10,000
- Johnson & Johnson Political Action CommitteePharmaceuticals$6,000
- Humana INC. Political Action CommitteeHealth Services/HMOs$6,000
- CVS Health PACPharmaceuticals$5,000
- Unitedhealth Group Incorporated PAC (Unitedhealth Group PAC)Health Services/HMOs$5,000
- Political Action Committee of the American Association of Orthopaedic Surgeons--PAC of AAOSHealth Professionals$5,000
- Abbott Laboratories Employee Political Action CommitteePharmaceuticals$5,000
- Novo Nordisk INC. PAC (Novo Nordisk PAC)Pharmaceuticals$5,000
- Alexion Pharmaceuticals INC. PACPharmaceuticals$5,000
The record
How Hern voted on 13 health bills.
The key health votes on the House floor in 2025 and 2026. Each links to the full roll call.
| Date | Bill | Vote | House |
|---|---|---|---|
| March 11, 2025 | H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025Full-year CR for FY2025 with Medicare telehealth and other health extenders | Yes | Passed |
| May 22, 2025 | H.R. 1, One Big Beautiful ActOne Big Beautiful Bill Act, House passage (Medicaid, ACA and HSA provisions; rural hospital fund) | Yes | Passed |
| June 4, 2025 | H.R. 2483, SUPPORT for Patients and Communities Reauthorization ActSUPPORT for Patients and Communities Reauthorization Act (opioid programs) | Yes | Passed |
| July 3, 2025 | H.R. 1, One Big Beautiful Bill ActOne Big Beautiful Bill Act, final passage (concur in Senate amendment); became Public Law 119-21 | Yes | Passed |
| September 19, 2025 | H.R. 5371, Continuing Appropriations and Extensions Act, 2026Continuing Appropriations and Extensions Act, 2026, House passage (health extenders) | Yes | Passed |
| November 12, 2025 | H.R. 5371, Continuing Appropriations and Extensions Act, 2026Continuing Appropriations and Extensions Act, 2026, final passage ending the shutdown; became Public Law 119-37 | Yes | Passed |
| December 17, 2025 | H.R. 6703, Lower Health Care Premiums for All Americans ActLower Health Care Premiums for All Americans Act | Yes | Passed |
| December 18, 2025 | H.R. 498, Do No Harm in Medicaid ActDo No Harm in Medicaid Act | Yes | Passed |
| January 22, 2026 | H.R. 7148, Consolidated Appropriations Act, 2026Consolidated Appropriations Act, 2026, House passage | Yes | Passed |
| February 3, 2026 | H.R. 7148, Consolidated Appropriations Act, 2026Consolidated Appropriations Act, 2026, final passage; became Public Law 119-75 | Yes | Passed |
| April 21, 2026 | H.R. 2493, Improving Care in Rural America Reauthorization ActImproving Care in Rural America Reauthorization Act | Yes | Passed |
| July 21, 2026 | H.R. 9770, Making continuing appropriations for fiscal year 2027, and for other purposesContinuing appropriations for FY2027 (H.R. 9770), House passage | Yes | Passed |
| September 1, 2026 | H.R. 6500, AGOA Extension ActH.R. 6500 as the vehicle for the Continuing Appropriations and Extensions Act, 2027; became Public Law 119-103 | Yes | Passed |
Source: Clerk of the House, roll-call vote XML, 2025 and 2026.
Stock trades
Healthcare stocks bought and sold.
Stock trades in healthcare companies, from periodic transaction reports filed in 2025 and 2026. Bonds and funds are not counted. An amended report replaces the trade it corrects.
| Date | Company | Trade | Amount | Owner |
|---|---|---|---|---|
| 12/31/2024 | DexCom, Inc. - Common Stock(DXCM) | Sale | $50,001-$100,000 | Joint |
| 12/31/2024 | Johnson & Johnson Common Stock(JNJ) | Sale | $100,001-$250,000 | Joint |
| 09/26/2025 | Masimo Corporation - Common Stock(MASI) | Sale | $15,001-$50,000 | Joint |
| 10/28/2025 | Boston Scientific Corporation Common Stock(BSX) | Partial sale | $15,001-$50,000 | Joint |
| 12/23/2025 | UnitedHealth Group Incorporated Common Stock(UNH) | Sale | $250,001-$500,000 | Joint |
| 02/09/2026 | Waters Corporation Common Stock(WAT) | Exchange | $1,001-$15,000 | Joint |
| 03/17/2026 | Becton, Dickinson and Company Common Stock(BDX) | Sale | $15,001-$50,000 | Joint |
| 03/24/2026 | Exact Sciences Corporation - Common Stock(EXAS) | Sale | $1,001-$15,000 | Dependent child |
| 03/16/2026 | IQVIA Holdings, Inc. Common Stock(IQV) | Sale | $50,001-$100,000 | Joint |
| 03/20/2026 | Medtronic plc. Ordinary Shares(MDT) | Sale | $15,001-$50,000 | Joint |
| 08/05/2026 | Organon & Co. Common Stock(OGN) | Sale | $1,001-$15,000 | Joint |
| 08/18/2026 | Biogen Inc. - Common Stock(BIIB) | Sale | $1,001-$15,000 | Self |
| 08/24/2026 | Medtronic plc. Ordinary Shares(MDT) | Sale | $15,001-$50,000 | Joint |
| 08/13/2026 | Waters Corporation Common Stock(WAT) | Sale | $1,001-$15,000 | Joint |
| 09/04/2026 | Boston Scientific Corporation Common Stock(BSX) | Partial sale | $50,001-$100,000 | Joint |
| 09/03/2026 | Boston Scientific Corporation Common Stock(BSX) | Sale | $1,001-$15,000 | Dependent child |
| 09/03/2026 | Boston Scientific Corporation Common Stock(BSX) | Sale | $1,001-$15,000 | Dependent child |
| 09/03/2026 | Boston Scientific Corporation Common Stock(BSX) | Sale | $1,001-$15,000 | Dependent child |
| 09/09/2026 | Boston Scientific Corporation Common Stock(BSX) | Sale | $50,001-$100,000 | Joint |
| 08/31/2026 | Boston Scientific Corporation Common Stock(BSX) | Sale | $15,001-$50,000 | Joint |
| 08/31/2026 | Danaher Corporation Common Stock(DHR) | Sale | $15,001-$50,000 | Joint |
| 09/02/2026 | Danaher Corporation Common Stock(DHR) | Partial sale | $1,001-$15,000 | Joint |
| 09/08/2026 | IQVIA Holdings, Inc. Common Stock(IQV) | Sale | $1,001-$15,000 | Dependent child |
| 09/14/2026 | IQVIA Holdings, Inc. Common Stock(IQV) | Sale | $15,001-$50,000 | Joint |
| 09/03/2026 | IQVIA Holdings, Inc. Common Stock(IQV) | Sale | $1,001-$15,000 | Dependent child |
| 08/27/2026 | Novartis AG Common Stock(NVS) | Sale | $15,001-$50,000 | Self |
| 08/31/2026 | Novo Nordisk A/S Common Stock(NVO) | Partial sale | $1,001-$15,000 | Self |
| 09/10/2026 | Novo Nordisk A/S Common Stock(NVO) | Sale | $1,001-$15,000 | Self |
| 09/15/2026 | STERIS plc(STE) | Sale | $15,001-$50,000 | Self |
| 09/10/2026 | UnitedHealth Group Incorporated Common Stock(UNH) | Sale | $15,001-$50,000 | Joint |
| 09/23/2026 | UnitedHealth Group Incorporated Common Stock(UNH) | Sale | $15,001-$50,000 | Joint |
On the committee
Seats and subcommittees.
- Full committeeMember
- Health SubcommitteeMember
- Tax SubcommitteeMember